Pharma News
Denosumab biosimilar by Celltrion for Osteoporosis: Likelihood of Approval
Denosumab biosimilar is under clinical development by Celltrion and currently in Phase I for Osteoporosis.
Source link
#Denosumab #biosimilar #Celltrion #Osteoporosis #Likelihood #Approval
